Internal Medicine, Hematology & Oncology · New York, NY
NPI
1962502013
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1050 Park Avenue
New York, NY, 10028
Phone (212) 860-3292
Groups this clinician bills Medicare through
Medicare paid, 2024
$750K
45,910 services
Medicare patients, 2024
962
Average age 77
Drug cost, 2024
$3.0M
1,053 prescriptions
Company payments, 2025
$23.84
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brenda D Panzera was code 88185 (surgical pathology examination), 4,676 times for 189 patients. In total Brenda D Panzera billed 45,910 services in 150 codes, and Medicare paid $750K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88185 Surgical Pathology Examination | Office | 4,676 | 189 | $22.00 | $103K |
| 36415 Venipuncture Blood Collection | Office | 2,222 | 871 | $8.65 | $19K |
| 85025 Blood Count | Office | 2,155 | 861 | $7.59 | $16K |
| 80053 Clinical Chemistry | Office | 2,056 | 848 | $10.31 | $21K |
| 82784 Immunoassay | Office | 1,461 | 320 | $9.09 | $13K |
| 99214 Office E&M - Established | Office | 1,434 | 650 | $108.93 | $156K |
| 84100 Clinical Chemistry | Office | 1,433 | 640 | $4.62 | $6,623 |
| 83615 Clinical Chemistry | Office | 1,428 | 646 | $5.90 | $8,425 |
| 83735 Clinical Chemistry | Office | 1,417 | 630 | $6.53 | $9,253 |
| 84550 Clinical Chemistry | Office | 1,410 | 628 | $4.41 | $6,212 |
| 82728 Clinical Chemistry | Office | 1,107 | 516 | $13.30 | $15K |
| 83540 Clinical Chemistry | Office | 1,104 | 515 | $6.32 | $6,972 |
| 83550 Clinical Chemistry | Office | 1,095 | 508 | $8.51 | $9,319 |
| 83521 Immunoassay | Office | 1,088 | 332 | $16.89 | $18K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 959 | 195 | $52.89 | $51K |
By year: 2022 $1.7M for 171,002 services; 2023 $1.3M for 89,786 services; 2024 $750K for 45,910 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 4,676 | 189 | $22.00 | $103K |
| 36415 Venipuncture Blood Collection | 2,222 | 871 | $8.65 | $19K |
| 85025 Blood Count | 2,155 | 861 | $7.59 | $16K |
| 80053 Clinical Chemistry | 2,056 | 848 | $10.31 | $21K |
| 82784 Immunoassay | 1,461 | 320 | $9.09 | $13K |
| 84100 Clinical Chemistry | 1,433 | 640 | $4.62 | $6,623 |
| 83615 Clinical Chemistry | 1,428 | 646 | $5.90 | $8,425 |
| 83735 Clinical Chemistry | 1,417 | 630 | $6.53 | $9,253 |
| 84550 Clinical Chemistry | 1,410 | 628 | $4.41 | $6,212 |
| 82728 Clinical Chemistry | 1,107 | 516 | $13.30 | $15K |
Medicare prescription drug claims, 2024
In 2024, the drug Brenda D Panzera prescribed most often to Medicare patients was Anastrozole, with 234 prescriptions and refills. In total Brenda D Panzera wrote 1,053 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 234 | 580 | 61 | $3,670 |
| Aranesp Darbepoetin Alfa In Polysorbat | 114 | 114 | 18 | $368K |
| Letrozole Generic | 72 | 209 | 26 | $1,852 |
| Eliquis Apixaban | 64 | 96 | 14 | $55K |
| Fulvestrant Generic | 59 | 59 | Under 11 | $56K |
| Exemestane Generic | 46 | 78 | 11 | $8,256 |
| Akynzeo Fosnetupitant/Palonosetron | 31 | 31 | Under 11 | $28K |
| Hydroxyurea Generic | 30 | 47 | Under 11 | $393 |
| Xgeva Denosumab | 28 | 28 | Under 11 | $86K |
| Revlimid Lenalidomide | 21 | 21 | Under 11 | $476K |
| Folic Acid Generic | 20 | 30 | Under 11 | $133 |
| Warfarin Sodium Generic | 19 | 31 | Under 11 | $124 |
| Verzenio Abemaciclib | 19 | 19 | Under 11 | $283K |
| Allopurinol Generic | 16 | 16 | Under 11 | $63.66 |
| Xarelto Rivaroxaban | 15 | 29 | Under 11 | $15K |
Brand drugs: 437 claims; generic drugs: 616 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brenda D Panzera $23.84 ($23.84 in general payments such as food, travel and fees) from 1 company. The largest payer was GlaxoSmithKline, LLC. with $23.84.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 1 | $23.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.